Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
calcium hydroxylapatite + hyaluronic acid
- Development stage
- Unknown
- Lead developer
- Dermax Aesthetics
- Modality
- Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems
- Administration
- Subcutaneous, Intradermal
01
Overview
CHArmacy is a hybrid biomaterial filler developed by Dermax Aesthetics, composed of calcium hydroxylapatite (CaHA) microspheres suspended in a cross-linked hyaluronic acid (HA) carrier gel. It is designed for aesthetic soft-tissue augmentation, including the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds and marionette lines, as well as volume restoration in the cheeks and chin. The filler employs a dual-action mechanism: the hyaluronic acid component provides immediate volumization and lifting, while the CaHA microspheres (25-45μm) act as a biostimulatory scaffold that promotes the long-term production of endogenous collagen and elastin. This combination results in superior elasticity and long-lasting aesthetic improvements typically persisting for 12 to 18 months.
- Brand names
- CHArmacy
- Other names
- CaHA fillerscalcium hydroxyapatite
02
Targets
ELN (Elastin)
Beyond the preview
Go deeper on calcium hydroxylapatite + hyaluronic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on calcium hydroxylapatite + hyaluronic acid.